CN104055841A - 一种治疗和预防近视的药物组合物 - Google Patents
一种治疗和预防近视的药物组合物 Download PDFInfo
- Publication number
- CN104055841A CN104055841A CN201410317709.4A CN201410317709A CN104055841A CN 104055841 A CN104055841 A CN 104055841A CN 201410317709 A CN201410317709 A CN 201410317709A CN 104055841 A CN104055841 A CN 104055841A
- Authority
- CN
- China
- Prior art keywords
- treatment
- myopia
- myopic
- preventing
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 208000001491 myopia Diseases 0.000 title abstract description 22
- 230000004379 myopia Effects 0.000 title abstract description 20
- 229940079593 drug Drugs 0.000 title description 7
- 238000011282 treatment Methods 0.000 claims abstract description 29
- 241000931705 Cicada Species 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims description 19
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 5
- 235000014435 Mentha Nutrition 0.000 claims description 4
- 241001072983 Mentha Species 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 229940023488 pill Drugs 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 3
- 239000003390 Chinese drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241001610349 Monetaria caputserpentis Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000000366 juvenile effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 24
- 230000004438 eyesight Effects 0.000 description 18
- 230000003203 everyday effect Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241001511570 Myopias Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 201000009406 ametropic amblyopia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- -1 dry Substances 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 201000010666 keratoconjunctivitis Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000004344 low myopia Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410317709.4A CN104055841B (zh) | 2014-07-05 | 2014-07-05 | 一种治疗和预防近视的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410317709.4A CN104055841B (zh) | 2014-07-05 | 2014-07-05 | 一种治疗和预防近视的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104055841A true CN104055841A (zh) | 2014-09-24 |
CN104055841B CN104055841B (zh) | 2015-08-19 |
Family
ID=51543960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410317709.4A Expired - Fee Related CN104055841B (zh) | 2014-07-05 | 2014-07-05 | 一种治疗和预防近视的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104055841B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104606367A (zh) * | 2015-01-13 | 2015-05-13 | 青岛市中心医院 | 治疗肝肾不足型近视眼的中药滴眼液及其制备方法 |
CN107496450A (zh) * | 2017-10-21 | 2017-12-22 | 深圳敬中堂科技有限公司 | 一种靶向干预wnt7b、sco2、zfp161基因预防与治疗近视的药物活性组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751358A (zh) * | 2014-01-20 | 2014-04-30 | 臧家良 | 一种用于矫治屈光不正眼疾的中药组合物 |
-
2014
- 2014-07-05 CN CN201410317709.4A patent/CN104055841B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751358A (zh) * | 2014-01-20 | 2014-04-30 | 臧家良 | 一种用于矫治屈光不正眼疾的中药组合物 |
Non-Patent Citations (2)
Title |
---|
毛丽萍等: "中西医结合治疗中小学生屈光不正116例疗效观察", 《甘肃中医学院学报》, no. 04, 30 December 1999 (1999-12-30) * |
魏菊仙: "中医治疗近视概况", 《江西中医药》, no. 01, 31 December 1986 (1986-12-31) * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104606367A (zh) * | 2015-01-13 | 2015-05-13 | 青岛市中心医院 | 治疗肝肾不足型近视眼的中药滴眼液及其制备方法 |
CN107496450A (zh) * | 2017-10-21 | 2017-12-22 | 深圳敬中堂科技有限公司 | 一种靶向干预wnt7b、sco2、zfp161基因预防与治疗近视的药物活性组合物 |
CN107496450B (zh) * | 2017-10-21 | 2020-07-10 | 深圳赞狮靶向基因工程有限公司 | 一种预防与治疗近视的药物活性组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN104055841B (zh) | 2015-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN102755593B (zh) | 一种治疗气瘿的中药组合物及其制备方法 | |
CN103099866A (zh) | 一种治疗焦虑、失眠的中药组合物及其制备方法 | |
CN106236875A (zh) | 一种清肝明目的中药组合物及其制备方法 | |
CN103381258A (zh) | 一种解郁安神颗粒及其口服液制备方法 | |
CN104055841B (zh) | 一种治疗和预防近视的药物组合物 | |
CN101884779A (zh) | 一种用于干预亚健康状态的黄精组合物及其制备方法 | |
CN104547622A (zh) | 一种治疗白内障的中药制剂及其制备方法 | |
CN104127702A (zh) | 一种治疗急性视神经炎的中药制剂及其制备方法 | |
CN103385329B (zh) | 一种治疗老人便秘的中草药冲泡茶 | |
CN105079676A (zh) | 一种治疗脂肪肝的药物及其制备方法 | |
CN104524058A (zh) | 一种治疗脑震荡的中药制剂及制备方法 | |
CN100998744A (zh) | 一种治疗小儿多动症的中成药 | |
CN104689107A (zh) | 一种用于治疗近视眼的中药配方及其制备方法 | |
CN104606367A (zh) | 治疗肝肾不足型近视眼的中药滴眼液及其制备方法 | |
CN103495101B (zh) | 一种用于治疗胃痛的中药组合物 | |
CN102370906B (zh) | 一种具有缓解视力疲劳作用的中药组合物及其制备方法 | |
CN104707031A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN105288290A (zh) | 一种防治视瞻昏渺的中药的制备方法 | |
CN105362913A (zh) | 一种治疗呃逆的药物及其制备方法 | |
CN104873655A (zh) | 一种治疗荨麻疹的中药组合物及制法 | |
CN104771616A (zh) | 一种治疗神经衰弱的中药制剂及其制备方法 | |
CN102327463A (zh) | 一种治疗眩晕症的中药组合物 | |
CN105194381A (zh) | 高中生服用的改善近视的制剂及制法 | |
CN105194110A (zh) | 防治近视的滋肝补肾制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: WANG GUIXIA Free format text: FORMER OWNER: ZHUANG CHENGLONG Effective date: 20150305 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ji Yuling Inventor before: Zhuang Chenglong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276017 LINYI, SHANDONG PROVINCE TO: 276401 LINYI, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: ZHUANG CHENGLONG TO: JI YULING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150305 Address after: 276401 Yishui City, Linyi province Yishui County town of new lane, No. 18 Applicant after: Wang Guixia Address before: 276017, Shandong Province, Luozhuang District, Linyi province pay Village Office Yin Zi village 262 Applicant before: Zhuang Chenglong |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170308 Address after: Haimen City, Jiangsu province 226100 Binhai New Area of Nantong port West Road No. 999 Patentee after: HAIMEN HUANGHAI PIONEER PARK SERVICES CO., LTD. Address before: 276401 Yishui City, Linyi province Yishui County town of new lane, No. 18 Patentee before: Wang Guixia |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180411 Address after: 277735 Zhoucun No. 108, Lu Tusheng Town, Cangshan, Linyi, Shandong Patentee after: Zhou Pingan Address before: Haimen City, Jiangsu province 226100 Binhai New Area of Nantong port West Road No. 999 Patentee before: HAIMEN HUANGHAI PIONEER PARK SERVICES CO., LTD. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150819 Termination date: 20210705 |